283 related articles for article (PubMed ID: 26621726)
1. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
[TBL] [Abstract][Full Text] [Related]
2. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.
Jiang Q; Crews LA; Barrett CL; Chun HJ; Court AC; Isquith JM; Zipeto MA; Goff DJ; Minden M; Sadarangani A; Rusert JM; Dao KH; Morris SR; Goldstein LS; Marra MA; Frazer KA; Jamieson CH
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):1041-6. PubMed ID: 23275297
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
4. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.
Zipeto MA; Court AC; Sadarangani A; Delos Santos NP; Balaian L; Chun HJ; Pineda G; Morris SR; Mason CN; Geron I; Barrett C; Goff DJ; Wall R; Pellecchia M; Minden M; Frazer KA; Marra MA; Crews LA; Jiang Q; Jamieson CHM
Cell Stem Cell; 2016 Aug; 19(2):177-191. PubMed ID: 27292188
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia stem cells.
Jamieson CH
Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
Abrahamsson AE; Geron I; Gotlib J; Dao KH; Barroga CF; Newton IG; Giles FJ; Durocher J; Creusot RS; Karimi M; Jones C; Zehnder JL; Keating A; Negrin RS; Weissman IL; Jamieson CH
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3925-9. PubMed ID: 19237556
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia stem cells.
Kavalerchik E; Goff D; Jamieson CH
J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
[TBL] [Abstract][Full Text] [Related]
8. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
9. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
[TBL] [Abstract][Full Text] [Related]
11. Role of Dok-1 and Dok-2 in leukemia suppression.
Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
[TBL] [Abstract][Full Text] [Related]
12. Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin.
Jin Y; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Zhou J; Pan J
Clin Cancer Res; 2017 Jun; 23(11):2842-2855. PubMed ID: 27852702
[No Abstract] [Full Text] [Related]
13. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
14. Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.
Krause DS; Lazarides K; Lewis JB; von Andrian UH; Van Etten RA
Blood; 2014 Feb; 123(9):1361-71. PubMed ID: 24394666
[TBL] [Abstract][Full Text] [Related]
15. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
16. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.
Goff DJ; Court Recart A; Sadarangani A; Chun HJ; Barrett CL; Krajewska M; Leu H; Low-Marchelli J; Ma W; Shih AY; Wei J; Zhai D; Geron I; Pu M; Bao L; Chuang R; Balaian L; Gotlib J; Minden M; Martinelli G; Rusert J; Dao KH; Shazand K; Wentworth P; Smith KM; Jamieson CA; Morris SR; Messer K; Goldstein LS; Hudson TJ; Marra M; Frazer KA; Pellecchia M; Reed JC; Jamieson CH
Cell Stem Cell; 2013 Mar; 12(3):316-28. PubMed ID: 23333150
[TBL] [Abstract][Full Text] [Related]
17. p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.
Salesse S; Dylla SJ; Verfaillie CM
Leukemia; 2004 Apr; 18(4):727-33. PubMed ID: 14961028
[TBL] [Abstract][Full Text] [Related]
18. An RNA editing fingerprint of cancer stem cell reprogramming.
Crews LA; Jiang Q; Zipeto MA; Lazzari E; Court AC; Ali S; Barrett CL; Frazer KA; Jamieson CH
J Transl Med; 2015 Feb; 13():52. PubMed ID: 25889244
[TBL] [Abstract][Full Text] [Related]
19. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
Hu Y; Chen Y; Douglas L; Li S
Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
[TBL] [Abstract][Full Text] [Related]
20. A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.
Park CS; Lewis AH; Chen TJ; Bridges CS; Shen Y; Suppipat K; Puppi M; Tomolonis JA; Pang PD; Mistretta TA; Ma L; Green MR; Rau R; Lacorazza HD
Blood; 2019 Nov; 134(22):1960-1972. PubMed ID: 31515251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
